Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 2536 entries
Sorted by: Best Match Show Resources per page
Suppression of aldosterone synthesis and secretion by ca(2+) channel antagonists.

International journal of endocrinology

Ikeda K, Isaka T, Fujioka K, Manome Y, Tojo K.
PMID: 23097668
Int J Endocrinol. 2012;2012:519467. doi: 10.1155/2012/519467. Epub 2012 Oct 11.

Aldosterone, a specific mineralocorticoid receptor (MR) agonist and a key player in the development of hypertension, is synthesized as a final product of renin-angiotensin-aldosterone system. Hypertension can be generally treated by negating the effects of angiotensin II through the...

Cite
Ikeda K, Isaka T, Fujioka K, et al. Suppression of aldosterone synthesis and secretion by ca(2+) channel antagonists. Int J Endocrinol. 2012;2012:519467doi: 10.1155/2012/519467.
Ikeda, K., Isaka, T., Fujioka, K., Manome, Y., & Tojo, K. (2012). Suppression of aldosterone synthesis and secretion by ca(2+) channel antagonists. International journal of endocrinology, 2012519467. https://doi.org/10.1155/2012/519467
Ikeda, Keiichi, et al. "Suppression of aldosterone synthesis and secretion by ca(2+) channel antagonists." International journal of endocrinology vol. 2012 (2012): 519467. doi: https://doi.org/10.1155/2012/519467
Ikeda K, Isaka T, Fujioka K, Manome Y, Tojo K. Suppression of aldosterone synthesis and secretion by ca(2+) channel antagonists. Int J Endocrinol. 2012;2012:519467. doi: 10.1155/2012/519467. Epub 2012 Oct 11. PMID: 23097668; PMCID: PMC3477571.
Copy Download .nbib Format: NLM
Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study.

BMC endocrine disorders

Sigurjonsdottir HA, Gronowitz M, Andersson O, Eggertsen R, Herlitz H, Sakinis A, Wangberg B, Johannsson G.
PMID: 22958674
BMC Endocr Disord. 2012 Sep 08;12:17. doi: 10.1186/1472-6823-12-17.

BACKGROUND: The existence of unilateral adrenal hyperplasia (AH) has been considered a rare cause of primary hyperaldosteronism (PA).METHODS: In a prospective study we screened for PA in a non-selected (NSP) and selected hypertensive population (SP), to define the cause...

Cite
Sigurjonsdottir HA, Gronowitz M, Andersson O, et al. Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study. BMC Endocr Disord. 2012;12:17doi: 10.1186/1472-6823-12-17.
Sigurjonsdottir, H. A., Gronowitz, M., Andersson, O., Eggertsen, R., Herlitz, H., Sakinis, A., Wangberg, B., & Johannsson, G. (2012). Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study. BMC endocrine disorders, 1217. https://doi.org/10.1186/1472-6823-12-17
Sigurjonsdottir, Helga Agusta, et al. "Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study." BMC endocrine disorders vol. 12 (2012): 17. doi: https://doi.org/10.1186/1472-6823-12-17
Sigurjonsdottir HA, Gronowitz M, Andersson O, Eggertsen R, Herlitz H, Sakinis A, Wangberg B, Johannsson G. Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study. BMC Endocr Disord. 2012 Sep 08;12:17. doi: 10.1186/1472-6823-12-17. PMID: 22958674; PMCID: PMC3515501.
Copy Download .nbib Format: NLM
Sodium handling is associated with liver function impairment and renin-aldosterone axis activity in patients with preascitic cirrhosis without hyponatremia.

Annals of gastroenterology

Tzamouranis D, Alexopoulou A, Dourakis SP, Stergiou GS.
PMID: 24713869
Ann Gastroenterol. 2012;25(3):254-257.

BACKGROUND: In cirrhotic patients awaiting liver transplantation, serum sodium concentration is related to prognosis. However, abnormalities in sodium homeostasis are evident even in the early preascitic stage of cirrhosis. We aimed to investigate whether parameters of renal sodium handling...

Cite
Tzamouranis D, Alexopoulou A, Dourakis SP, et al. Sodium handling is associated with liver function impairment and renin-aldosterone axis activity in patients with preascitic cirrhosis without hyponatremia. Ann Gastroenterol. 2012;25(3):254-257
Tzamouranis, D., Alexopoulou, A., Dourakis, S. P., & Stergiou, G. S. (2012). Sodium handling is associated with liver function impairment and renin-aldosterone axis activity in patients with preascitic cirrhosis without hyponatremia. Annals of gastroenterology, 25(3), 254-257.
Tzamouranis, Dimitris, et al. "Sodium handling is associated with liver function impairment and renin-aldosterone axis activity in patients with preascitic cirrhosis without hyponatremia." Annals of gastroenterology vol. 25,3 (2012): 254-257.
Tzamouranis D, Alexopoulou A, Dourakis SP, Stergiou GS. Sodium handling is associated with liver function impairment and renin-aldosterone axis activity in patients with preascitic cirrhosis without hyponatremia. Ann Gastroenterol. 2012;25(3):254-257. PMID: 24713869; PMCID: PMC3959362.
Copy Download .nbib Format: NLM
Role of ANO4 in regulation of aldosterone secretion in the zona glomerulosa of the human adrenal gland.

Lancet (London, England)

Maniero C, Zhou J, Shaikh LH, Azizan EA, McFarlane I, Neogi S, Scudieri P, Galietta LJ, Brown MJ.
PMID: 26312884
Lancet. 2015 Feb 26;385:S62. doi: 10.1016/S0140-6736(15)60377-4.

BACKGROUND: Cell origin of aldosterone-producing adenomas, a major cause of hypertension, is unknown. A less common subtype of these adenomas, composed of cells resembling zona glomerulosa, have mutations in genes ATP1A1 and CACNA1D. To understand whether the adenomas originate...

Cite
Maniero C, Zhou J, Shaikh LH, et al. Role of ANO4 in regulation of aldosterone secretion in the zona glomerulosa of the human adrenal gland. Lancet. 2015;385:S62doi: 10.1016/S0140-6736(15)60377-4.
Maniero, C., Zhou, J., Shaikh, L. H., Azizan, E. A., McFarlane, I., Neogi, S., Scudieri, P., Galietta, L. J., & Brown, M. J. (2015). Role of ANO4 in regulation of aldosterone secretion in the zona glomerulosa of the human adrenal gland. Lancet (London, England), 385S62. https://doi.org/10.1016/S0140-6736(15)60377-4
Maniero, Carmela, et al. "Role of ANO4 in regulation of aldosterone secretion in the zona glomerulosa of the human adrenal gland." Lancet (London, England) vol. 385 (2015): S62. doi: https://doi.org/10.1016/S0140-6736(15)60377-4
Maniero C, Zhou J, Shaikh LH, Azizan EA, McFarlane I, Neogi S, Scudieri P, Galietta LJ, Brown MJ. Role of ANO4 in regulation of aldosterone secretion in the zona glomerulosa of the human adrenal gland. Lancet. 2015 Feb 26;385:S62. doi: 10.1016/S0140-6736(15)60377-4. PMID: 26312884.
Copy Download .nbib Format: NLM
Evaluation of clinical outcomes and costs based on prescribed dose level of renin-angiotensin-aldosterone system inhibitors.

The American journal of managed care

Epstein M, Alvarez PJ, Reaven NL, Funk SE, McGaughey KJ, Brenner MS, Benton W, Golestaneh L.
PMID: 27668789
Am J Manag Care. 2016 Aug;22(11):s311-s324.

No abstract available.

Cite
Epstein M, Alvarez PJ, Reaven NL, et al. Evaluation of clinical outcomes and costs based on prescribed dose level of renin-angiotensin-aldosterone system inhibitors. Am J Manag Care. 2016;22(11):s311-s324
Epstein, M., Alvarez, P. J., Reaven, N. L., Funk, S. E., McGaughey, K. J., Brenner, M. S., Benton, W., & Golestaneh, L. (2016). Evaluation of clinical outcomes and costs based on prescribed dose level of renin-angiotensin-aldosterone system inhibitors. The American journal of managed care, 22(11), s311-s324.
Epstein, Murray, et al. "Evaluation of clinical outcomes and costs based on prescribed dose level of renin-angiotensin-aldosterone system inhibitors." The American journal of managed care vol. 22,11 (2016): s311-s324.
Epstein M, Alvarez PJ, Reaven NL, Funk SE, McGaughey KJ, Brenner MS, Benton W, Golestaneh L. Evaluation of clinical outcomes and costs based on prescribed dose level of renin-angiotensin-aldosterone system inhibitors. Am J Manag Care. 2016 Aug;22(11):s311-s324. PMID: 27668789.
Copy Download .nbib Format: NLM
Evaluating the relationship of blood pressure, plasma angiotensin peptides and aldosterone with cognitive functions in patients with hypertension.

EXCLI journal

Sen S, Gürel N, Ufuktepe B, Özünal ZG, Büyüklü Ç, Üresin Y.
PMID: 28507470
EXCLI J. 2017 Mar 10;16:245-255. doi: 10.17179/excli2016-725. eCollection 2017.

Renin Angiotensin Aldosterone System (RAAS) plays an important role in the development of hypertension. On the other hand, hypertension is a well-known and independent risk factor for cognitive impairment. The aim of the present study was to evaluate the...

Cite
Sen S, Gürel N, Ufuktepe B, et al. Evaluating the relationship of blood pressure, plasma angiotensin peptides and aldosterone with cognitive functions in patients with hypertension. EXCLI J. 2017;16:245-255doi: 10.17179/excli2016-725.
Sen, S., Gürel, N., Ufuktepe, B., Özünal, Z. G., Büyüklü, �. �., & Üresin, Y. (2017). Evaluating the relationship of blood pressure, plasma angiotensin peptides and aldosterone with cognitive functions in patients with hypertension. EXCLI journal, 16245-255. https://doi.org/10.17179/excli2016-725
Sen, Selçuk, et al. "Evaluating the relationship of blood pressure, plasma angiotensin peptides and aldosterone with cognitive functions in patients with hypertension." EXCLI journal vol. 16 (2017): 245-255. doi: https://doi.org/10.17179/excli2016-725
Sen S, Gürel N, Ufuktepe B, Özünal ZG, Büyüklü Ç, Üresin Y. Evaluating the relationship of blood pressure, plasma angiotensin peptides and aldosterone with cognitive functions in patients with hypertension. EXCLI J. 2017 Mar 10;16:245-255. doi: 10.17179/excli2016-725. eCollection 2017. PMID: 28507470; PMCID: PMC5427471.
Copy Download .nbib Format: NLM
Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia.

Kidney international

Bushinsky DA, Williams GH, Pitt B, Weir MR, Freeman MW, Garza D, Stasiv Y, Li E, Berman L, Bakris GL.
PMID: 26376130
Kidney Int. 2015 Dec;88(6):1427-1433. doi: 10.1038/ki.2015.270. Epub 2015 Sep 16.

Patients with chronic kidney disease (CKD) have a high risk of hyperkalemia, which increases mortality and can lead to renin-angiotensin-aldosterone system inhibitor (RAASi) dose reduction or discontinuation. Patiromer, a nonabsorbed potassium binder, has been shown to normalize serum potassium...

Cite
Bushinsky DA, Williams GH, Pitt B, et al. Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia. Kidney Int. 2015;88(6):1427-1433doi: 10.1038/ki.2015.270.
Bushinsky, D. A., Williams, G. H., Pitt, B., Weir, M. R., Freeman, M. W., Garza, D., Stasiv, Y., Li, E., Berman, L., & Bakris, G. L. (2015). Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia. Kidney international, 88(6), 1427-1433. https://doi.org/10.1038/ki.2015.270
Bushinsky, David A, et al. "Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia." Kidney international vol. 88,6 (2015): 1427-1433. doi: https://doi.org/10.1038/ki.2015.270
Bushinsky DA, Williams GH, Pitt B, Weir MR, Freeman MW, Garza D, Stasiv Y, Li E, Berman L, Bakris GL. Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia. Kidney Int. 2015 Dec;88(6):1427-1433. doi: 10.1038/ki.2015.270. Epub 2015 Sep 16. PMID: 26376130; PMCID: PMC4678168.
Copy Download .nbib Format: NLM
Cardio-renal protection through renin-angiotensin-aldosterone system inhibition: current knowledge and new perspectives.

European heart journal. Cardiovascular pharmacotherapy

Paolillo S, Perrone Filardi P.
PMID: 27533983
Eur Heart J Cardiovasc Pharmacother. 2015 Apr;1(2):132-3. doi: 10.1093/ehjcvp/pvv008. Epub 2015 Feb 24.

No abstract available.

Cite
Paolillo S, Perrone Filardi P. Cardio-renal protection through renin-angiotensin-aldosterone system inhibition: current knowledge and new perspectives. Eur Heart J Cardiovasc Pharmacother. 2015;1(2):132-3doi: 10.1093/ehjcvp/pvv008.
Paolillo, S., & Perrone Filardi, P. (2015). Cardio-renal protection through renin-angiotensin-aldosterone system inhibition: current knowledge and new perspectives. European heart journal. Cardiovascular pharmacotherapy, 1(2), 132-3. https://doi.org/10.1093/ehjcvp/pvv008
Paolillo, Stefania, and Perrone Filardi, Pasquale. "Cardio-renal protection through renin-angiotensin-aldosterone system inhibition: current knowledge and new perspectives." European heart journal. Cardiovascular pharmacotherapy vol. 1,2 (2015): 132-3. doi: https://doi.org/10.1093/ehjcvp/pvv008
Paolillo S, Perrone Filardi P. Cardio-renal protection through renin-angiotensin-aldosterone system inhibition: current knowledge and new perspectives. Eur Heart J Cardiovasc Pharmacother. 2015 Apr;1(2):132-3. doi: 10.1093/ehjcvp/pvv008. Epub 2015 Feb 24. PMID: 27533983.
Copy Download .nbib Format: NLM
The Challenges of Arterial Hypertension.

Frontiers in cardiovascular medicine

Rossi GP.
PMID: 26664874
Front Cardiovasc Med. 2015 Feb 03;2:2. doi: 10.3389/fcvm.2015.00002. eCollection 2015.

No abstract available.

Cite
Rossi GP. The Challenges of Arterial Hypertension. Front Cardiovasc Med. 2015;2:2doi: 10.3389/fcvm.2015.00002.
Rossi, G. P. (2015). The Challenges of Arterial Hypertension. Frontiers in cardiovascular medicine, 22. https://doi.org/10.3389/fcvm.2015.00002
Rossi, Gian Paolo. "The Challenges of Arterial Hypertension." Frontiers in cardiovascular medicine vol. 2 (2015): 2. doi: https://doi.org/10.3389/fcvm.2015.00002
Rossi GP. The Challenges of Arterial Hypertension. Front Cardiovasc Med. 2015 Feb 03;2:2. doi: 10.3389/fcvm.2015.00002. eCollection 2015. PMID: 26664874; PMCID: PMC4668841.
Copy Download .nbib Format: NLM
[First Experience of Clinical Application of LCZ696 an AT1-angiotensin Receptors and Neprilysin Inhibitor in Patients With Chronic Heart Failure and Reduced Ejection Fraction].

Kardiologiia

Kobalava ZD, Pavlikova EP, Averkov OA, Merai I, Babaeva LA, Amirbegishvili IA, Kotovskaya YV, Moiseev VS.
PMID: 28294911
Kardiologiia. 2015 Jul;55(7):14-25.

Simultaneous inhibition of the renin-angiotensin-aldosterone system and the system of degradation of natriuretic peptides can potentially provide unique therapeutic effects in patients with chronic heart failure (CHF) with reduced ejection fraction (EF). Aim of this study was to assess...

Cite
Kobalava ZD, Pavlikova EP, Averkov OA, et al. [First Experience of Clinical Application of LCZ696 an AT1-angiotensin Receptors and Neprilysin Inhibitor in Patients With Chronic Heart Failure and Reduced Ejection Fraction]. Kardiologiia. 2015;55(7):14-25
Kobalava, Z. D., Pavlikova, E. P., Averkov, O. A., Merai, I., Babaeva, L. A., Amirbegishvili, I. A., Kotovskaya, Y. V., & Moiseev, V. S. (2015). [First Experience of Clinical Application of LCZ696 an AT1-angiotensin Receptors and Neprilysin Inhibitor in Patients With Chronic Heart Failure and Reduced Ejection Fraction]. Kardiologiia, 55(7), 14-25.
Kobalava, Zh D, et al. "[First Experience of Clinical Application of LCZ696 an AT1-angiotensin Receptors and Neprilysin Inhibitor in Patients With Chronic Heart Failure and Reduced Ejection Fraction]." Kardiologiia vol. 55,7 (2015): 14-25.
Kobalava ZD, Pavlikova EP, Averkov OA, Merai I, Babaeva LA, Amirbegishvili IA, Kotovskaya YV, Moiseev VS. [First Experience of Clinical Application of LCZ696 an AT1-angiotensin Receptors and Neprilysin Inhibitor in Patients With Chronic Heart Failure and Reduced Ejection Fraction]. Kardiologiia. 2015 Jul;55(7):14-25. Russian. PMID: 28294911.
Copy Download .nbib Format: NLM
Aldosterone predicts major adverse cardiovascular events in patients with acute myocardial infarction.

Heart Asia

Yuyun MF, Jutla SK, Quinn PA, Ng LL.
PMID: 27326041
Heart Asia. 2012 Aug 24;4(1):102-7. doi: 10.1136/heartasia-2012-010129. eCollection 2012.

OBJECTIVE: Aldosterone is associated with increased mortality in chronic heart failure patients and correlates with adverse outcomes after an acute myocardial infarction (AMI) in smaller cohorts. We evaluated the prognostic significance of plasma aldosterone in a large cohort of...

Cite
Yuyun MF, Jutla SK, Quinn PA, et al. Aldosterone predicts major adverse cardiovascular events in patients with acute myocardial infarction. Heart Asia. 2012;4(1):102-7doi: 10.1136/heartasia-2012-010129.
Yuyun, M. F., Jutla, S. K., Quinn, P. A., & Ng, L. L. (2012). Aldosterone predicts major adverse cardiovascular events in patients with acute myocardial infarction. Heart Asia, 4(1), 102-7. https://doi.org/10.1136/heartasia-2012-010129
Yuyun, Matthew Fomonyuy, et al. "Aldosterone predicts major adverse cardiovascular events in patients with acute myocardial infarction." Heart Asia vol. 4,1 (2012): 102-7. doi: https://doi.org/10.1136/heartasia-2012-010129
Yuyun MF, Jutla SK, Quinn PA, Ng LL. Aldosterone predicts major adverse cardiovascular events in patients with acute myocardial infarction. Heart Asia. 2012 Aug 24;4(1):102-7. doi: 10.1136/heartasia-2012-010129. eCollection 2012. PMID: 27326041; PMCID: PMC4832614.
Copy Download .nbib Format: NLM
RETRACTED: Relationship Between Aldosterone Synthase CYP1A1 MspI Gene Polymorphism and Prostate Cancer Risk.

Technology in cancer research & treatment

Ou C, Zhao Y, Liu JH, Zhu B, Li PZ, Zhao HL.
PMID: 26763619
Technol Cancer Res Treat. 2017 Feb;16(1):NP6-NP11. doi: 10.1177/1533034615625519. Epub 2016 Jun 22.

No abstract available.

Cite
Ou C, Zhao Y, Liu JH, et al. RETRACTED: Relationship Between Aldosterone Synthase CYP1A1 MspI Gene Polymorphism and Prostate Cancer Risk. Technol Cancer Res Treat. 2016;16(1):NP6-NP11doi: 10.1177/1533034615625519.
Ou, C., Zhao, Y., Liu, J. H., Zhu, B., Li, P. Z., & Zhao, H. L. (2017). RETRACTED: Relationship Between Aldosterone Synthase CYP1A1 MspI Gene Polymorphism and Prostate Cancer Risk. Technology in cancer research & treatment, 16(1), NP6-NP11. https://doi.org/10.1177/1533034615625519
Ou, Chao, et al. "RETRACTED: Relationship Between Aldosterone Synthase CYP1A1 MspI Gene Polymorphism and Prostate Cancer Risk." Technology in cancer research & treatment vol. 16,1 (2017): NP6-NP11. doi: https://doi.org/10.1177/1533034615625519
Ou C, Zhao Y, Liu JH, Zhu B, Li PZ, Zhao HL. RETRACTED: Relationship Between Aldosterone Synthase CYP1A1 MspI Gene Polymorphism and Prostate Cancer Risk. Technol Cancer Res Treat. 2017 Feb;16(1):NP6-NP11. doi: 10.1177/1533034615625519. Epub 2016 Jun 22. PMID: 26763619; PMCID: PMC5616114.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 2536 entries